FI922710A0 - ELIMINERING AV AKTIVERADE LYMFOCYTER. - Google Patents

ELIMINERING AV AKTIVERADE LYMFOCYTER.

Info

Publication number
FI922710A0
FI922710A0 FI922710A FI922710A FI922710A0 FI 922710 A0 FI922710 A0 FI 922710A0 FI 922710 A FI922710 A FI 922710A FI 922710 A FI922710 A FI 922710A FI 922710 A0 FI922710 A0 FI 922710A0
Authority
FI
Finland
Prior art keywords
lymfocyter
aktiverade
eliminering
octadecylglycero
mitogens
Prior art date
Application number
FI922710A
Other languages
Finnish (fi)
Inventor
Eberhard Wecker
Anneliese Schimpl
Rabbe Nordstroem
Original Assignee
Medmark Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmark Pharma Gmbh filed Critical Medmark Pharma Gmbh
Publication of FI922710A0 publication Critical patent/FI922710A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

2-Methyl-1-octadecylglycero-(3)-phosphocholine is suitable for killing mammalian lymphocytes activated by antigens or mitogens.
FI922710A 1989-12-12 1992-06-11 ELIMINERING AV AKTIVERADE LYMFOCYTER. FI922710A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (en) 1989-12-12 1989-12-12 ELIMINATION OF ACTIVATED LYMPHOCYTES
PCT/EP1990/002233 WO1991008746A1 (en) 1989-12-12 1990-12-11 Killing of activated lymphocytes

Publications (1)

Publication Number Publication Date
FI922710A0 true FI922710A0 (en) 1992-06-11

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922710A FI922710A0 (en) 1989-12-12 1992-06-11 ELIMINERING AV AKTIVERADE LYMFOCYTER.

Country Status (13)

Country Link
EP (1) EP0505414B1 (en)
JP (1) JPH05504132A (en)
AT (1) ATE102038T1 (en)
AU (1) AU638086B2 (en)
CA (1) CA2071520C (en)
DE (2) DE3941009A1 (en)
DK (1) DK0505414T3 (en)
ES (1) ES2062754T3 (en)
FI (1) FI922710A0 (en)
HU (1) HU217586B (en)
NO (1) NO922304D0 (en)
RU (1) RU2100025C1 (en)
WO (1) WO1991008746A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (en) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Use of edelfosin for treatment of brain tumors, especially by oral administration
DE19829448A1 (en) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholine (ET180CH3) for the treatment of human breast cancer
US7998945B2 (en) * 2005-12-23 2011-08-16 Jado Technologies Gmbh Methods for the treatment and amelioration of atopic dermatitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES

Also Published As

Publication number Publication date
DK0505414T3 (en) 1994-05-09
HU217586B (en) 2000-02-28
HUT60927A (en) 1992-11-30
ATE102038T1 (en) 1994-03-15
NO922304L (en) 1992-06-11
ES2062754T3 (en) 1994-12-16
DE59004836D1 (en) 1994-04-07
RU2100025C1 (en) 1997-12-27
HU9201976D0 (en) 1992-09-28
AU638086B2 (en) 1993-06-17
EP0505414B1 (en) 1994-03-02
NO922304D0 (en) 1992-06-11
CA2071520A1 (en) 1991-06-13
JPH05504132A (en) 1993-07-01
AU6954391A (en) 1991-07-18
DE3941009A1 (en) 1991-06-13
EP0505414A1 (en) 1992-09-30
WO1991008746A1 (en) 1991-06-27
CA2071520C (en) 2002-10-01

Similar Documents

Publication Publication Date Title
NO881491D0 (en) PROCEDURE FOR CULTURING LEUKOCYTES.
IT1100477B (en) PROCEDURE AND MEANS FOR THE MICROBIAL EXPRESSION OF POLYPERTIDS
EP0261224A4 (en) Synthetic htlv-iii peptides, compositions and uses thereof.
DK386789D0 (en) fermenter
FR2472401B1 (en) MOTORCYCLE-TOY DRIVEN BY FLYWHEEL
IT8026684A0 (en) KEYBOARD LIGHTING DEVICE.
NO901801D0 (en) PLANTING CULTURE APPARATUS.
DE59008348D1 (en) Corpuscular beam device.
FI922710A0 (en) ELIMINERING AV AKTIVERADE LYMFOCYTER.
AP8800109A0 (en) "Heterocyclic insecticides".
IT8721945A0 (en) PROCEDURE FOR THE FRAGRANCE OF BOOKS, DEVICE FOR THE IMPLEMENTATION OF SAID PROCEDURE
AU564040B2 (en) 1,2,3,4 - tetrahydro-1-aminomethyl-4-phenyl - isoquinolines
ES2032573T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 4,4-DIMETIL-TETRAHIDROPIR-2-ONA.
FR2654839B1 (en) APPARATUS FOR STUDYING THE STRATOSPHERE BY LASER SURVEY.
FR2654624B1 (en) ATMOSPHERE.
IT8819474A0 (en) DEVICE FOR INSPECTION OF CONTAINER FILE.
SU1417444A1 (en) 2,4-Diphenyl-3 (4-acetoxy-4-methylhexin-2-yl) -3-azabicyclo [3.3.1] nonan-9-one exhibiting anti-inflammatory activity
IT8819486A0 (en) DEVICE FOR UNIFORM DISPLAY LIGHTING.
IT8722276V0 (en) DEVICE FOR THE INTRODUCTION OF ANTIFECONDATIVES.
IT1228272B (en) MICROPELLETIZATION PROCEDURE OF PYRITE ASH.
BR8706557A (en) MFD 1200
NO874181D0 (en) MOVEMENT DISABILITY DEVICE.
NO882700L (en) DEVICE FOR DEPARTMENT OF OBJECTS.
BR8901853A (en) MOTOR-GENERATOR SET
SU1269465A1 (en) Method of obtaining 2-aniline-7-hydroxi-6h-1,3,4-thiadziazipyne of common formula

Legal Events

Date Code Title Description
FD Application lapsed